By Liz Moyer
Investing.com — Novavax Inc (NASDAQ:) jumped 20% on Monday as traders cheered promising information about its Covid-19 vaccine candidate.
The corporate mentioned final month is two-shot drug is 89.3% efficient, and has proven constructive outcomes even towards harder virus strains within the U.Ok. and South Africa. Its part 3 medical trials have been executed within the U.Ok.
Analysts have been elevating their worth targets on the inventory. On Monday, B. Riley analysts, who charge it a purchase, moved their goal as much as $334 from $223. Final week, JP Morgan, which additionally charges the inventory a purchase, raised its worth goal to $295 from $216. The inventory at present trades round $264, setting a 52-week excessive on Monday.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or injury because of reliance on the knowledge together with information, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding varieties potential.
